The United States has launched an official trade investigation concerning German medicine pricing policies. Washington claims that Berlin maintains artificial price caps on pharmaceuticals, resulting in a market disparity where the United States pays significantly more for identical medical products than the German market.
According to Euronews, the investigation seeks to determine whether these pricing structures constitute unfair trade practices. Should the probe conclude that Germany’s policies are discriminatory, the United States has indicated that it may respond by imposing punitive tariffs. The inquiry remains pending as authorities review the current bilateral trade arrangements regarding pharmaceutical costs.
Source: Euronews. Read the original report ↗